Physician profile
Varsha Atuluru
NPI 1174101950
$11,196.00
in general payments reported to CMS, 2019-2025
13 companies · $5,092 in 2025
The $5,092 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $6,104 · 2025: $5,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,117 · Food and Beverage: $3,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,117.01 |
| Food and Beverage | $3,078.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,270.51 | 2024-2025 | Hoffmann, Ortholoc 3di, Augment Injectable |
| Orthofix Medical, INC. | $2,247.23 | 2024 | Truelok |
| Paragon 28, INC. | $2,123.81 | 2024-2025 | Portfolio |
| Acumed LLC | $1,617.39 | 2024 | Acumed, Osteomed |
| Arthrex, INC. | $1,318.31 | 2025 | |
| Sanara Medtech INC. | $146.16 | 2025 | Celleraterx |
| Treace Medical Concepts, INC. | $135.73 | 2025 | |
| Integra Lifesciences Corporation | $124.81 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Gramercy Extremity Orthopedics LLC | $78.32 | 2025 | |
| Fortis Surgical, LLC | $47.02 | 2025 | |
| Biocomposites INC | $36.67 | 2024 | |
| Medtronic, INC. | $26.06 | 2025 | Inceptiv |
| Organogenesis INC. | $23.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varsha Atuluru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.